Z-0288-2007
OptiVantage DH Power Injection System
Mallinckrodt, Inc. / initiated 2006-11-07 / Terminated
Mallinckrodt Inc began a recall of OptiVantage DH Power Injection System on . The reason FDA records is "The flow rate programmed on the console may be changed without automatically updating the flow rate programmed on the power head. The injector will always inject in accordance with the parameters shown on the power...". As of , the recall status on record is Terminated.
Recall record
- Recall number
- Z-0288-2007
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Mallinckrodt, Inc.
- Product
- OptiVantage DH Power Injection System.
- Product code
- CXT
- Reason for recall
- The flow rate programmed on the console may be changed without automatically updating the flow rate programmed on the power head. The injector will always inject in accordance with the parameters shown on the power head. If this lack of synchronization occurs and is not noticed by the clinican, contrast would be injected at a higher or lower flow rate than desired.
- FDA root cause
- Other
- Action
- The recalling firm sent a letter dated 11/7/2006 to all consignees.
- Quantity in commerce
- 1348 devices.
- Distribution
- Worldwide distribution ---- including USA and countries of Australia, Belgium, Brazil, Canada, Chile, Columbia, Denmark, Mexico, Panama, Puerto Rico, Singapore and South Africa.
- Product codes and lots
- All codes.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
